Table 1 Clinical and biochemical characteristics of 30-day survivor and non-survivor MMCAI patients
Non-survivors (n = 34) | Survivors (n = 34) | P-value | |
|---|---|---|---|
Age (years) - median (p 25–75) | 63 (53–70) | 59 (47–68) | 0.36 |
Arterial hypertension - n (%) | 16 (47.1) | 19 (55.9) | 0.63 |
Gender female - n (%) | 13 (38.2) | 14 (41.2) | 0.99 |
COPD - n (%) | 1 (2.9) | 1 (2.9) | 0.99 |
Diabetes mellitus - n (%) | 9 (26.5) | 4 (11.8) | 0.22 |
Heart failure - n (%) | 1 (2.9) | 1 (2.9) | 0.99 |
Chronic renal failure - n (%) | 2 (5.9) | 2 (5.9) | 0.99 |
Temperature (°C) - median (p 25–75) | 36.9 (36.0–37.3) | 36.4 (36.0–37.0) | 0.15 |
GCS score - median (p 25–75) | 6 (3–7) | 7 (6–8) | 0.01 |
Lactic acid (mmol/L)-median (p 25–75) | 1.55 (1.00–2.70) | 1.20 (0.90–1.70) | 0.05 |
Sodium (mEq/L)- median (p 25–75) | 140 (139–145) | 139 (136–145) | 0.38 |
Bilirubin (mg/dl) - median (p 25–75) | 0.60 (0.33–1.10) | 0.60 (0.40–0.83) | 0.95 |
Creatinine (mg/dl) - median (p 25–75) | 1.00 (0.70–1.25) | 0.80 (0.60–1.13) | 0.19 |
Glycemia (g/dL) - median (p 25–75) | 136 (118–162) | 127 (100–170) | 0.40 |
PaO2 (mmHg) - median (p 25–75) | 115 (94–267) | 156 (105–293) | 0.26 |
PaO2/FI02 ratio - median (p 25–75) | 254 (192–325) | 300 (198–369) | 0.24 |
Platelets - median*103/mm3 (p 25–75) | 175 (136–216) | 202 (171–265) | 0.02 |
Leukocytes-median*103/mm3 (p 25–75) | 13.9 (9.7–20.1) | 12.4 (9.6–16.9) | 0.32 |
Hemoglobin (g/dL) - median (p 25–75) | 12.5 (11.0–14.8) | 12.1 (11.4–14.0) | 0.81 |
Fibrinogen (mg/dl) - median (p 25–75) | 419 (337–631) | 443 (416–489) | 0.90 |
INR - median (p 25–75) | 1.20 (1.01–1.31) | 1.06 (1.00–1.20) | 0.07 |
aPTT (seconds) - median (p 25–75) | 27 (26–32) | 28 (25–30) | 0.91 |
APACHE-II score - median (p 25–75) | 22 (19–27) | 20 (16–25) | 0.06 |
Thrombolysis - n (%) | 10 (29.4) | 11 (32.4) | 0.99 |
Volumen infarction (ml) - median (p25–75) | 180 (60–277) | 173 (100–231) | 0.64 |
Haemorrhagic transformation - n (%) | 6 (17.6) | 7 (20.6) | 0.99 |
Midline shift (mm) - median (p 25–75) | 9.0 (3.5–15.0) | 6.0 (2.5–11.5) | 0.43 |
Decompressive craniectomy – n (%) | 7 (20.6) | 9 (26.5) | 0.78 |
Malondialdehyde (nmol/mL)-median (p 25–75) | 2.96 (2.01–4.44) | 1.84 (1.33–2.28) | < 0.001 |